Trial Profile
Study of Levodopa and Rotigotine in patients with Parkinson's disease : A biomarker analysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Levodopa/benserazide (Primary) ; Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Pharmacodynamics
- 26 Sep 2016 New trial record